0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial | 
Richard I. G. Holt, PhD, FRCP
JAMA Pediatr. 2015;169(5):427-428. doi:10.1001/jamapediatrics.2015.144.

Original Investigation | 
Wendy Camelo Castillo, PhD; Kim Boggess, MD; Til Stürmer, PhD; et al.
JAMA Pediatr. 2015;169(5):452-458. doi:10.1001/jamapediatrics.2015.74.
Includes: Supplemental Content

Original Investigation |  ONLINE ONLY
David M. Rubin, MD, MSCE; Amanda R. Kreider, BS, BA; Meredith Matone, MHS; et al.
JAMA Pediatr. 2015;169(4):e150285. doi:10.1001/jamapediatrics.2015.0285.
Includes: Supplemental Content

Original Investigation | 
Adam J. Spanier, MD, PhD, MPH; Robert S. Kahn, MD, MPH; Allen R. Kunselman, MA; et al.
JAMA Pediatr. 2014;168(12):1131-1137. doi:10.1001/jamapediatrics.2014.1397.

Original Investigation |  ONLINE ONLY
Desirée Valera-Gran, MHP; Manuela García de la Hera, MPH, PhD; Eva María Navarrete-Muñoz, MPH, PhD; et al.
JAMA Pediatr. 2014;168(11):e142611. doi:10.1001/jamapediatrics.2014.2611.

Original Investigation | 
L. Charles Bailey, MD, PhD; Christopher B. Forrest, MD, PhD; Peixin Zhang, PhD; et al.
JAMA Pediatr. 2014;168(11):1063-1069. doi:10.1001/jamapediatrics.2014.1539.

Research Letter |  FREE
Thomas Delate, PhD, MS; Yardlee S. Kauffman, PharmD, MPH; Sheila R. Botts, PharmD; et al.
JAMA Pediatr. 2014;168(7):679-681. doi:10.1001/jamapediatrics.2014.224.

Editorial | 
Miriam Cooper, MRCPsych, MSc; Kate Langley, PhD; Anita Thapar, FRCPsych, PhD
JAMA Pediatr. 2014;168(4):306-307. doi:10.1001/jamapediatrics.2013.5292.

Original Investigation |  FREE
Zeyan Liew, MPH; Beate Ritz, MD, PhD; Cristina Rebordosa, MD, PhD; et al.
JAMA Pediatr. 2014;168(4):313-320. doi:10.1001/jamapediatrics.2013.4914.
Includes: Supplemental Content

JAMA Pediatrics Clinical Challenge | 
Ashika Odhav, MD; Chirag Odhav; Nimesh A. Dayal, MBBCh, MRCP, MSc
JAMA Pediatr. 2014;168(3):287-288. doi:10.1001/jamapediatrics.2013.3763.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Otolaryngology–Head & Neck Surgery
Original Investigation  | 
Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy
Eleonoor A. R. Theunissen, MD; Charlotte L. Zuur, MD, PhD; Katarzyna Jóźwiak, PhD; et al.
JAMA Ophthalmology
Original Investigation  | 
Association of Compounded Bevacizumab With Postinjection Endophthalmitis
Brian L. VanderBeek, MD, MPH; Sarah G. Bonaffini, BS; Liyuan Ma, MS
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Oncology
Invited Commentary  | 
PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events
Benjamin Movsas, MD